{"id":6718,"date":"2021-07-20T17:23:35","date_gmt":"2021-07-20T17:23:35","guid":{"rendered":"https:\/\/haugpartners.com\/article\/can-biologics-manufacturers-face-antitrust-risk-for-pointing-out-that-biosimilars-are-different-2\/"},"modified":"2024-09-26T09:05:47","modified_gmt":"2024-09-26T09:05:47","slug":"can-biologics-manufacturers-face-antitrust-risk-for-pointing-out-that-biosimilars-are-different-2","status":"publish","type":"article","link":"https:\/\/haugpartners.com\/article\/can-biologics-manufacturers-face-antitrust-risk-for-pointing-out-that-biosimilars-are-different-2\/","title":{"rendered":"Can Biologics Manufacturers Face Antitrust Risk For Pointing Out That Biosimilars Are Different?"},"featured_media":5455,"template":"","categories":[98],"acf":[],"_links":{"self":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article\/6718"}],"collection":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/types\/article"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media\/5455"}],"wp:attachment":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media?parent=6718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/categories?post=6718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}